Tubulin-binding dibenz[c,e]oxepines: Part 2 Structural variation and biological evaluation as tumour vasculature disrupting agents

Hadfield, JA ORCID: https://orcid.org/0000-0001-7984-8319, Rossington, SB, Wallace, TW, Shnyder, SD and Williams, KJ 2017, 'Tubulin-binding dibenz[c,e]oxepines: Part 2 Structural variation and biological evaluation as tumour vasculature disrupting agents' , Bioorganic and Medicinal Chemistry, 25 (5) , pp. 1630-1642.

[img]
Preview
PDF - Accepted Version
Download (870kB) | Preview

Abstract

5,7-Dihydro-3,9,10,11-tetramethoxybenz[c,e]oxepin-4-ol 1, prepared from a dibenzyl ether precursor via Pd-catalysed intramolecular direct arylation, possesses broad-spectrum in vitro cytotoxicity towards various tumour cell lines, and induces vascular shutdown, necrosis and growth delay in tumour xenografts in mice at sub-toxic doses. The biological properties of 1 and related compounds can be attributed to their ability to inhibit microtubule assembly at the micromolar level, by binding reversibly to the same site of the tubulin αβ-heterodimer as colchicine 2 and the allocolchinol, N-acetylcolchinol 4.

Item Type: Article
Schools: Schools > School of Environment and Life Sciences > Biomedical Research Centre
Journal or Publication Title: Bioorganic and Medicinal Chemistry
Publisher: Elsevier
ISSN: 0968-0896
Related URLs:
Funders: UMIP
Depositing User: JA Hadfield
Date Deposited: 30 Jan 2017 09:55
Last Modified: 15 Feb 2022 21:39
URI: https://usir.salford.ac.uk/id/eprint/41266

Actions (login required)

Edit record (repository staff only) Edit record (repository staff only)

Downloads

Downloads per month over past year